Eterna Therapeutics
ERNA
#10512
Rank
S$11.1 M
Marketcap
S$9.52
Share price
-6.34%
Change (1 day)
159.22%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): S-$98.70

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is S-$98.79. In 2022 the company made an earnings per share (EPS) of S-$162.08 an increase over its 2021 EPS that were of S-$1,071.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$98.70
2022S-$162.08-84.86%
2021S-$1,071

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
S$3.30-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
S-$2.74-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S-$2.60-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S-$0.17-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
S$1.76-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
S$0.91-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA